New approaches to engaging the public in considering regenerative medicine’s wicked policy issues

To further public understanding of regenerative medicine, EuroStemCell has published lay summaries for all articles from the latest Regenerative Medicine special focus issue.

Go to the profile of Regenerative Medicine
Dec 11, 2017
0
0

EuroStemCell have launched a digital platform to accompany the publication of the Regenerative Medicine two-part Special Focus Issue entitled “Regenerative Medicine in Society: Interdisciplinary Perspectives”. The platform presents lay summaries of each article in the issue which are freely available to all in order to engage and educate non-experts on the key issues surrounding regenerative medicine.

You can now read the lay summary for the article entitled 'Wicked policy issues in regenerative medicine and the need to explore new avenues for public engagement' from Amy Zarzeczny & Kathleen McNutt [1].

The field of regenerative medicine promises important advances in scientific understanding and clinical treatments, but it also raises various ethical, commercial and social issues, including the concerns associated with the growing private market for unproven stem cell treatments. Determining how to respond to these kinds of complex issues requires engaging key stakeholders, including the public. Public information campaigns (PICs) traditionally seek to distribute information to audiences in order to influence perspectives and behaviour. Online resources and PICs using social media platforms could allow for higher levels of engagement and broader scope of information sharing than PICs using traditional print materials are able to, particularly if they take advantage of ‘network governance’ strategies.

What questions & challenges are raised? What insight and direction does this give for research policies? To find out, read the full lay summary on the EuroStemCell website here: 
https://www.eurostemcell.org/regenerative-medicine-society/new-approaches-engaging-public-considering-regenerative-medicines

The full original article can be accessed here:
https://www.futuremedicine.com/doi/10.2217/rme-2017-0108


References

[1] Zarzeczny A, McNutt KWicked policy issues in regenerative medicine & the need to explore new avenues for public engagement. Regen. Med. 12(7), 749–752 (2017).

Go to the profile of Regenerative Medicine

Regenerative Medicine

Journal, Future Science Group

Regenerative Medicine is an award-winning peer-reviewed journal, in print and web formats. The journal provides a forum to address the important challenges and advances in stem cell research and regenerative medicine, delivering this essential information in concise, clear and attractive article formats. Among other indexing services Regenerative Medicine is listed by MEDLINE/Index Medicus, EMBASE/Excerpta Medica, Chemical Abstracts, Science Citation Index Expanded™ (SciSearch®), Emcare, Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index®, Journal Citation Reports/Science Edition®, Scopus® with an Impact Factor of 2.786 (2014). Each issue contains expertly drafted Reviews, Original Research articles, Perspectives, Editorials, topical insight from international leaders in their field, and additional added-value content. The Senior Editor of the journal is Professor Chris Mason, University College London. You can find out more about Regenerative Medicine at our website (www.future-science-group.com/journalprofile/regenerative-medicine/), where you can find the aims and scope of the journal and details of our international editorial board.

No comments yet.